Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2022

Published date22 September 2021
Citation86 FR 52819
Record Number2021-20737
SectionPresidential Documents
CourtExecutive Office Of The President
Presidential Documents
52819
Federal Register
Vol. 86, No. 181
Wednesday, September 22, 2021
Title 3—
The President
Presidential Determination No. 2021–13 of September 15, 2021
Presidential Determination on Major Drug Transit or Major
Illicit Drug Producing Countries for Fiscal Year 2022
Memorandum for the Secretary of State
By the authority vested in me as President by the Constitution and the
laws of the United States, including section 706(1) of the Foreign Relations
Authorization Act, Fiscal Year 2003 (Public Law 107–228) (FRAA), I hereby
identify the following countries as major drug transit or major illicit drug
producing countries: Afghanistan, The Bahamas, Belize, Bolivia, Burma, Co-
lombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guate-
mala, Haiti, Honduras, India, Jamaica, Laos, Mexico, Nicaragua, Pakistan,
Panama, Peru, and Venezuela.
A country’s presence on the foregoing list is neither a reflection of its
government’s counterdrug efforts nor level of cooperation with the United
States. Consistent with the statutory definition of a major drug transit or
major illicit drug producing country set forth in section 481(e)(2) and (5)
of the Foreign Assistance Act of 1961, as amended (Public Law 87–195)
(FAA), the reason countries are placed on the list is the combination of
geographic, commercial, and economic factors that allow drugs to be transited
or produced, even if a government has engaged in robust and diligent
narcotics control and law enforcement measures.
Pursuant to section 706(2)(A) of the FRAA, I hereby designate Bolivia and
Venezuela as having failed demonstrably to make substantial efforts during
the previous 12 months to both adhere to their obligations under international
counternarcotics agreements and to take the measures required by section
489(a)(1) of the FAA. Included with this determination are justifications
for the designations of Bolivia and Venezuela, as required by section 706(2)(B)
of the FRAA. I have also determined, in accordance with provisions of
section 706(3)(A) of the FRAA, that United States programs that support
Bolivia and Venezuela are vital to the national interests of the United States.
The ongoing drug addiction and overdose epidemic in the United States
is one of the foremost public health priorities of my Administration, and
addressing this epidemic will require both new domestic investments and
greater cooperation with foreign partners to target illicit drug suppliers and
the criminal organizations that profit from them. While creating our first-
year drug policy priorities, my Administration outlined a strategy that in-
cludes expanding access to prevention, treatment, evidence-based harm re-
duction, and recovery support services in order to curb the drug addiction
and overdose epidemic. The American Rescue Plan Act of 2021 is an invest-
ment in these priorities, committing nearly $4 billion to support behavioral
health and substance use disorder programs.
My Administration’s Fiscal Year 2022 Budget request itemizes $10.7 billion
to support research, prevention, treatment, evidence-based harm reduction,
and recovery support services, with targeted investments to meet the needs
of populations at greatest risk for overdose and substance use disorder.
The Budget request also includes significant investments to reduce the supply
of illicit drugs originating from beyond our borders.
The United States is committed to working together with the countries
of the Western Hemisphere as neighbors and partners to meet our shared
challenges of drug trafficking and use. My Administration will seek to expand
VerDate Sep<11>2014 17:52 Sep 21, 2021 Jkt 253250 PO 00000 Frm 00003 Fmt 4705 Sfmt 4790 E:\FR\FM\22SEO0.SGM 22SEO0
52820
Federal Register / Vol. 86, No. 181 / Wednesday, September 22, 2021 / Presidential Documents
cooperation with key partners, such as Mexico and Colombia, to shape
a collective and comprehensive response and expand efforts to address
the production and trafficking of dangerous synthetic drugs that are respon-
sible for many of our overdose deaths, particularly fentanyl, fentanyl ana-
logues, and methamphetamine. In Mexico, we must continue to work together
to intensify efforts to dismantle transnational criminal organizations and
their networks, increase prosecutions of criminal leaders and facilitators,
and strengthen efforts to seize illicit assets. In Bolivia, I encourage the
government to take additional steps to safeguard the country’s licit coca
markets from criminal exploitation and reduce illicit coca cultivation that
continues to exceed legal limits under Bolivia’s domestic laws for medicinal
and traditional use. In addition, the United States will look to expand
cooperation with China, India, and other chemical source countries in order
to disrupt the global flow of synthetic drugs and their precursor chemicals.
You are authorized and directed to submit this designation, with the Bolivia
and Venezuela memoranda of justification, under section 706 of the FRAA,
to the Congress, and to publish this determination in the Federal Register.
THE WHITE HOUSE,
Washington, September 15, 2021
[FR Doc. 2021–20737
Filed 9–21–21; 11:15 am]
Billing code 4710–10–P
VerDate Sep<11>2014 17:52 Sep 21, 2021 Jkt 253250 PO 00000 Frm 00004 Fmt 4705 Sfmt 4790 E:\FR\FM\22SEO0.SGM 22SEO0
BIDEN.EPS</GPH>

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT